{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:23:58Z","timestamp":1790177038474,"version":"4.1.0"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institutes of Health - National Eye Institute Career Development Award","award":["NEI K23EY026998"],"award-info":[{"award-number":["NEI K23EY026998"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY02162"],"award-info":[{"award-number":["EY02162"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research to Prevent Blindnessew York, NY"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ajoc.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T13:42:35Z","timestamp":1518097355000},"page":"117-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Combination nivolumab- and cabiralizumab-associated acute bilateral anterior and posterior scleritis and anterior uveitis"],"prefix":"10.1016","volume":"10","author":[{"given":"John A.","family":"Gonzales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Shantha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.ajoc.2018.02.005_bib1","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajoc.2018.02.005_bib2","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.5301\/ejo.5000724","article-title":"A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab","volume":"26","author":"Abu Samra","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2018.02.005_bib3","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jcjo.2015.09.008","article-title":"Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: case report","volume":"51","author":"Basilious","year":"2016","journal-title":"Can J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2018.02.005_bib4","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1002\/phar.1839","article-title":"A rare case of pembrolizumab-induced uveitis in a patient with metastatic melanoma","volume":"36","author":"Hanna","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajoc.2018.02.005_bib5","first-page":"1","article-title":"Bilateral anterior uveitis associated with nivolumab therapy","author":"Karlin","year":"2016","journal-title":"Ocul Immunol Inflamm"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993617301044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993617301044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:56:17Z","timestamp":1762527377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993617301044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":5,"alternative-id":["S2451993617301044"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.02.005","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination nivolumab- and cabiralizumab-associated acute bilateral anterior and posterior scleritis and anterior uveitis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}